The information below is disclosed in accordance with AIM Rule 26 and details are updated on a regular basis:
Business Description – Click here
Directors Names & Biographies - Click here
Corporate Governance – Click here
UK Takeover Code - The Company is subject to the UK City Code on Takeovers and Mergers.
Current constitutional documents such as articles of association and memorandum of association - Click here
Details of any other exchanges or trading platforms - The company’s shares are not traded on any other stock exchange.
The number of aim securities in issue (noting any held as treasury shares) – Click here
The identity and percentage holdings of significant shareholders – Click here
Details of any restrictions on the transfer of aim securities– Click here
Annual and interim financial reports - – Click here
Regulatory news – Click here
Aim admission document and circulars - Click here
Advisors – Click here
Country of incorporation: England and Wales
Company registration number: 09761507
Main country of operation: United Kingdom
Latest reports

31 March 2022
Interim Presentation 31 December 2021
Investor News
Monday May 30, 2022
Genedrive gets UK coronavirus test device approval
Friday April 01, 2022
Inspiration Healthcare and genedrive launch test for neonatal hearing loss risk
Tuesday March 29, 2022
McKay Securities reveals possible rival to agreed offer from Workspace